Literature DB >> 21233674

Loss of E-cadherin independently predicts the lymph node status in colorectal cancer.

E Karamitopoulou1, I Zlobec, Es Patsouris, G Peros, A Lugli.   

Abstract

BACKGROUND: The identification of biomarkers that improve risk stratification in patients with colorectal cancer (CRC) is still a challenge. The objective of our study was to identify independent protein markers as predictors of lymph node (N) stage in CRC.
METHODS: Tumour specimens from 221 CRC patients were mounted onto a multiple-punch tissue microarray and evaluated for 21 tumour related factors and one host related factor involved in CRC carcinogenesis, namely β-catenin, E-cadherin, EGFR, pERK, RHAMM, pAKT, pSMAD2, p21, p16, Bcl-2, Ki-67, APAF-1, MST1, RKIP, VEGF, EphB2, MMP7, Laminin5γ2, MUC1, CDX2, caspase-3 as well as intra-tumoural and stromal CD8+ tumour infiltrating lymphocytes (iTILs and sTILs).
RESULTS: Node positive cancers showed significant losses for p21 (p = 0.026), Bcl-2 (p = 0.027), APAF-1 (p = 0.033), EphB2 (p = 0.006), E-cadherin (p < 0.001), RKIP (p = 0.019), CD8+ iTILs and sTILs (p < 0.001 and p = 0.008, respectively) and cytoplasmic MST1 (p = 0.014). Based on the area under the receiver operating characteristic curve (AUC) EphB2, E-cadherin, iTILs and sTILs were identified as potential predictors of N stage (AUC values >0.6), but only loss of E-cadherin was an independent predictor in multivariate analysis.
CONCLUSIONS: E-cadherin appears to be a strong predictor of N stage in CRC and should be considered in pre-operative and post-operative management of colon and rectal cancer patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233674     DOI: 10.1097/PAT.0b013e3283425b7f

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  18 in total

Review 1.  Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review.

Authors:  L Ung; A K-Y Lam; D L Morris; T C Chua
Journal:  Clin Transl Oncol       Date:  2014-01-24       Impact factor: 3.405

2.  Functional characterization of recurrent FOXA2 mutations seen in endometrial cancers.

Authors:  Robert Neff; Craig M Rush; Blair Smith; Floor J Backes; David E Cohn; Paul J Goodfellow
Journal:  Int J Cancer       Date:  2018-09-29       Impact factor: 7.396

Review 3.  Cadherins down-regulation: towards a better understanding of their relevance in colorectal cancer.

Authors:  Lorena Losi; Tommaso Zanocco-Marani; Alexis Grande
Journal:  Histol Histopathol       Date:  2020-06-22       Impact factor: 2.303

4.  Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer.

Authors:  Iver Nordentoft; Lars Dyrskjøt; Julie S Bødker; Peter J Wild; Arndt Hartmann; Simone Bertz; Jan Lehmann; Torben F Orntoft; Karin Birkenkamp-Demtroder
Journal:  BMC Cancer       Date:  2011-04-14       Impact factor: 4.430

Review 5.  MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies.

Authors:  Yunhui Zeng; Qiongwen Zhang; Yujie Zhang; Minxun Lu; Yang Liu; Tianying Zheng; Shijian Feng; Meiqin Hao; Huashan Shi
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

6.  Gemifloxacin, a fluoroquinolone antimicrobial drug, inhibits migration and invasion of human colon cancer cells.

Authors:  Jung-Yu Kan; Ya-Ling Hsu; Yen-Hsu Chen; Tun-Chieh Chen; Jaw-Yuan Wang; Po-Lin Kuo
Journal:  Biomed Res Int       Date:  2013-12-10       Impact factor: 3.411

7.  High frequency of CD8 positive lymphocyte infiltration correlates with lack of lymph node involvement in early rectal cancer.

Authors:  Silvio Däster; Serenella Eppenberger-Castori; Christian Hirt; Inti Zlobec; Tarik Delko; Christian A Nebiker; Savas D Soysal; Francesca Amicarella; Giandomenica Iezzi; Giuseppe Sconocchia; Michael Heberer; Alessandro Lugli; Giulio C Spagnoli; Christoph Kettelhack; Luigi Terracciano; Daniel Oertli; Urs von Holzen; Luigi Tornillo; Raoul A Droeser
Journal:  Dis Markers       Date:  2014-12-30       Impact factor: 3.434

8.  Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.

Authors:  Pavlos Lampropoulos; Adamantia Zizi-Sermpetzoglou; Spyros Rizos; Alkiviadis Kostakis; Nikolaos Nikiteas; Athanasios G Papavassiliou
Journal:  Tumour Biol       Date:  2012-01-26

9.  Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β.

Authors:  Valentina Mele; Manuele G Muraro; Diego Calabrese; Dennis Pfaff; Nunzia Amatruda; Francesca Amicarella; Brynn Kvinlaug; Chiara Bocelli-Tyndall; Ivan Martin; Therese J Resink; Michael Heberer; Daniel Oertli; Luigi Terracciano; Giulio C Spagnoli; Giandomenica Iezzi
Journal:  Int J Cancer       Date:  2014-01-30       Impact factor: 7.396

10.  Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.

Authors:  Sang-Jeon Lee; Song Yi Choi; Wun-Jae Kim; Meiying Ji; Taek-Gu Lee; Bo-Ra Son; Soon Man Yoon; Rohyun Sung; Eun Jeoung Lee; Sei Jin Youn; Seon Mee Park
Journal:  Diagn Pathol       Date:  2013-06-19       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.